Historical salary details - Mr. Gregory Norden, Independent Director, Praxis Precision Medicines Inc
Mr. Gregory Norden is the Independent Director of Praxis Precision Medicines Inc. They also hold 2 other positions in Zoetis Inc - Ordinary Shares - Class A and Royalty Pharma plc - Ordinary Shares - Class A.
Mr. Gregory Norden
Independent Director
-
Gross Remuneration
-
Current Company
Praxis Precision Medicines Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Praxis Precision Medicines Inc | Independent Director | - | - |
| 2024 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2024 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | 389.8 K | -7.9 % |
| 2023 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 365 K | 0.0 % |
| 2023 | Praxis Precision Medicines Inc | Independent Director | 82.9 K | -59.5 % |
| 2022 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | 423.4 K | 7.5 % |
| 2022 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 365 K | 2.8 % |
| 2022 | Nanostring Technologies Inc | Independent Director | 238.9 K | -16.6 % |
| 2022 | Praxis Precision Medicines Inc | Independent Director | 204.8 K | -47.1 % |
| 2021 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | 393.8 K | -70.4 % |
| 2021 | Praxis Precision Medicines Inc | Independent Director | 387.3 K | -13.7 % |
| 2021 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 355 K | 0.0 % |
| 2021 | Nanostring Technologies Inc | Independent Director | 286.3 K | 19.7 % |
| 2020 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | 1.3 M | - |
| 2020 | Praxis Precision Medicines Inc | Independent Director | 449.0 K | 614.8 % |
| 2020 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 355 K | 0.0 % |
| 2020 | Nanostring Technologies Inc | Independent Director | 239.2 K | 12.7 % |
| 2019 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 355 K | 9.2 % |
| 2019 | Nanostring Technologies Inc | Independent Director | 212.3 K | 103.4 % |
| 2019 | Praxis Precision Medicines Inc | Independent Director | 62.8 K | - |
| 2019 | Royalty Pharma plc - Ordinary Shares - Class A | Independent Director | - | - |
| 2018 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 325 K | 0.0 % |
| 2018 | Nanostring Technologies Inc | Independent Director | 104.4 K | -32.4 % |
| 2017 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 325 K | 10.2 % |
| 2017 | Nanostring Technologies Inc | Independent Director | 154.3 K | 43.5 % |
| 2016 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 295 K | 0.0 % |
| 2016 | Nanostring Technologies Inc | Independent Director | 107.6 K | 1.3 % |
| 2015 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 295 K | 11.3 % |
| 2015 | Nanostring Technologies Inc | Independent Director | 106.2 K | 5.2 % |
| 2014 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 265 K | 0.0 % |
| 2014 | Nanostring Technologies Inc | Independent Director | 101.0 K | 109.5 % |
| 2013 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | 265 K | - |
| 2013 | Nanostring Technologies Inc | Independent Director | 48.2 K | 33.2 % |
| 2012 | Nanostring Technologies Inc | Independent Director | 36.2 K | - |
| 2012 | Zoetis Inc - Ordinary Shares - Class A | Independent Director | - | - |